Sign In

Stephen Kennedy

Head of Technical Operations at CRISPR Therapeutics

Stephen Kennedy is a seasoned senior executive with a strong background in the biopharmaceutical industry, specializing in business and operations management, process research and development, and biologics manufacturing.

His expertise encompasses gene editing, gene therapy, autologous cell therapy, therapeutic protein technologies, and cGMP manufacturing.

Stephen has a track record of driving process and organizational performance enhancements leading to increased profitability in his past roles.

He possesses international management experience with successful leadership tenures in Belgium, France, and Finland.

Education-wise, Stephen holds an MBA and Executive MBA from Boston University, an MS in Chemical Engineering from the University of Rochester, and a BSE in Chemical Engineering with a Bio Option from the University of Michigan.

In terms of his professional experience, Stephen has held notable positions such as Head Of Technical Operations at CRISPR Therapeutics, SVP and Head of Technical Operations at Casebia Therapeutics, EVP and Chief Operating Officer at Histogenics Corporation, Chief Technology Officer at Histogenics Corporation, and more.

He has also served in various capacities at institutions like the University of Michigan, Massachusetts Institute of Technology, Genzyme, Novartis/MIT Center for Continuous Manufacturing, and Eastman Kodak.

Throughout his career, Stephen Kennedy has demonstrated a deep understanding of biopharmaceutical operations, strategic leadership, and technical expertise, making him a valuable asset in the industry.

His rich professional background and academic qualifications position him as a top candidate for roles requiring a blend of business acumen, technical proficiency, and strategic vision.

Stephen Kennedy
Add to my network

Location

Greater Boston